| Accentia Biopharmaceutica ... | ABPI | United States | 0.38 | 27 | 9 | 4 | 14 | 9 | 53.84 % | 34.61 % | 1 |
| Adherex Technologies Inc | RV4A.BE | Canada | 0.00 | 13 | 1 | 1 | 2 | 2 | 15.38 % | 15.38 % | 0 |
| Akesis Pharmaceuticals Inc | AKES.PK | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Alexza Pharmaceuticals Inc | ALXA | United States | 0.07 | 87 | 8 | 9 | 27 | 21 | 40.90 % | 31.81 % | 21 |
| Alfacell Corp | ACEL | United States | 0.36 | 23 | 4 | 1 | 8 | 4 | 42.10 % | 21.05 % | 4 |
| Allon Therapeutics Inc | NPCUF.PK | United States | -2.00 | 1 | 0 | 1 | 0 | 1 | 0.00 % | 100.00 % | 0 |
| Allos Therapeutics Inc | ALTH | United States | 0.11 | 109 | 12 | 9 | 36 | 29 | 42.85 % | 34.52 % | 25 |
| Alnylam Pharmaceuticals Inc | ALNY | United States | 0.04 | 217 | 28 | 31 | 75 | 65 | 45.73 % | 39.63 % | 53 |
| Alseres Pharmaceutical Inc | ALSE | United States | 0.00 | 10 | 1 | 1 | 2 | 2 | 20.00 % | 20.00 % | 0 |
| Altus Pharmaceuticals Inc | ALTU | United States | 0.18 | 110 | 12 | 11 | 39 | 25 | 46.98 % | 30.12 % | 27 |
| Amylin Pharmaceuticals Inc | AMLN | United States | 0.03 | 373 | 37 | 47 | 137 | 118 | 46.91 % | 40.41 % | 81 |
| Anadys Pharmaceuticals Inc | ANDS | United States | -0.50 | 8 | 0 | 1 | 0 | 1 | 0.00 % | 25.00 % | 4 |
| Anika Therapeutics Inc | ANIK | United States | 0.39 | 49 | 8 | 1 | 21 | 11 | 48.83 % | 25.58 % | 6 |
| Antigenics Inc | AJ8.BE | United States | -0.10 | 56 | 7 | 10 | 17 | 19 | 35.41 % | 39.58 % | 8 |
| Api Group | API.L | United Kingdom | -2.00 | 2 | 0 | 2 | 0 | 2 | 0.00 % | 100.00 % | 0 |
| Arius Research Inc | AIURF.PK | Canada | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Atherogenics Inc | AGIX | United States | -0.02 | 48 | 7 | 7 | 16 | 17 | 38.09 % | 40.47 % | 6 |
| Avalon Pharmaceuticals Inc | AVRX | United States | 0.14 | 29 | 3 | 3 | 8 | 4 | 28.57 % | 14.28 % | 1 |
| Avanir Pharmaceuticals | AVNR | United States | 2.00 | 1 | 1 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Avax Technologies Inc | AVXT.PK | United States | -0.20 | 6 | 1 | 1 | 1 | 2 | 20.00 % | 40.00 % | 1 |
| Avi Biopharma Inc | AVII | United States | 0.06 | 56 | 6 | 5 | 16 | 14 | 34.04 % | 29.78 % | 9 |
| Benda Pharmaceutical Inc | BPMA.PK | United States | 1.00 | 1 | 0 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Biomarin Pharmaceutical Inc | BMRN | United States | 0.26 | 437 | 70 | 32 | 184 | 132 | 53.48 % | 38.37 % | 93 |
| Biopure Corp | BPUR | United States | -1.33 | 5 | 0 | 2 | 0 | 2 | 0.00 % | 66.66 % | 2 |
| Cadus Corp | CD1.BE | United States | 0.00 | 5 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Carrington Labs Inc | CARN | United States | 1.50 | 2 | 1 | 0 | 2 | 0 | 100.00 % | 0.00 % | 0 |
| China Shineway Pharmaceut ... | CSWYF.PK | Cayman Islands | -2.00 | 3 | 0 | 2 | 0 | 2 | 0.00 % | 100.00 % | 1 |
| Clinuvel Pharmaceuticals ... | UR9.BE | Australia | 1.33 | 4 | 2 | 0 | 2 | 0 | 66.66 % | 0.00 % | 1 |
| Corcept Therapeutics Inc | CORT | United States | -0.47 | 25 | 3 | 6 | 5 | 13 | 21.73 % | 56.52 % | 2 |
| Cortex Pharmaceuticals Inc | COR | United States | 0.15 | 27 | 5 | 4 | 10 | 7 | 38.46 % | 26.92 % | 1 |
| Critical Therapeutics Inc | CRTX | United States | -0.32 | 36 | 4 | 7 | 7 | 15 | 20.58 % | 44.11 % | 2 |
| Cv Therapeutics Inc | CVTX | United States | -0.17 | 184 | 18 | 27 | 53 | 69 | 37.06 % | 48.25 % | 41 |
| Cyclacel Pharmaceuticals Inc | CYCC | United States | 0.38 | 34 | 7 | 2 | 16 | 9 | 51.61 % | 29.03 % | 3 |
| Cytrx Corp | CYTR | United States | -0.05 | 100 | 12 | 13 | 27 | 30 | 36.98 % | 41.09 % | 27 |
| Dendreon Corp | DNDN | United States | 0.10 | 160 | 22 | 20 | 56 | 45 | 44.09 % | 35.43 % | 33 |
| Discovery Laboratories Inc | DSCO | United States | -0.10 | 109 | 8 | 15 | 34 | 36 | 39.53 % | 41.86 % | 23 |
| Dov Pharmaceutical Inc | DOVPW.PK | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Dyax Corp | DYAX | United States | 0.18 | 85 | 12 | 9 | 33 | 22 | 44.59 % | 29.72 % | 11 |
| Epicept Corp | EPCT | United States | 0.28 | 10 | 3 | 2 | 3 | 2 | 42.85 % | 28.57 % | 3 |
| Favrille Inc | FVRL | United States | 0.66 | 11 | 2 | 0 | 2 | 0 | 33.33 % | 0.00 % | 5 |
| Gilead Sciences Inc | GILD | United States | -0.01 | 1300 | 111 | 94 | 435 | 463 | 43.71 % | 46.53 % | 305 |
| Grifols S A | GIFLF.PK | Spain | -2.00 | 8 | 0 | 5 | 0 | 5 | 0.00 % | 100.00 % | 3 |
| Guangzhou Pharmaceutical Ltd | GZPHY.PK | United States | -1.00 | 2 | 0 | 0 | 0 | 1 | 0.00 % | 100.00 % | 1 |
| Hard To Treat Diseases Inc | HTDS.PK | United States | -0.66 | 3 | 0 | 1 | 0 | 1 | 0.00 % | 33.33 % | 0 |
| Havelock Europa | HVE.L | United Kingdom | -2.00 | 2 | 0 | 2 | 0 | 2 | 0.00 % | 100.00 % | 0 |
| Hemispherx Biopharma Inc | HEB | United States | -0.11 | 29 | 3 | 4 | 6 | 8 | 23.07 % | 30.76 % | 3 |
| Hollis Eden Pharmaceutica ... | HEPH | United States | -0.10 | 41 | 4 | 7 | 14 | 15 | 35.89 % | 38.46 % | 2 |
| Imarx Therapeutics Inc | P1X.BE | United States | -1.00 | 1 | 0 | 0 | 0 | 1 | 0.00 % | 100.00 % | 0 |
| Imclone Sys Inc | IMCL | United States | 0.14 | 296 | 49 | 26 | 120 | 105 | 47.05 % | 41.17 % | 41 |
| Immtech International Inc | IMM | United States | -0.68 | 19 | 1 | 4 | 2 | 12 | 10.52 % | 63.15 % | 0 |
| Insmed Inc | INSM | United States | -0.22 | 40 | 4 | 8 | 9 | 13 | 25.71 % | 37.14 % | 5 |
| Inspire Pharmaceuticals Inc | ISPH | United States | -0.13 | 93 | 9 | 14 | 31 | 37 | 38.27 % | 45.67 % | 12 |
| Integrated Pharmaceutical ... | INTP.PK | United States | 2.00 | 1 | 1 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Introgen Therapeutics Inc | INGN | United States | -0.20 | 46 | 4 | 8 | 12 | 16 | 30.76 % | 41.02 % | 7 |
| Isis Pharmaceuticals Calif | ISIS | United States | 0.17 | 278 | 42 | 36 | 114 | 83 | 52.53 % | 38.24 % | 61 |
| Ista Pharmaceuticals Inc | ISTA | United States | -0.05 | 45 | 6 | 8 | 16 | 16 | 42.10 % | 42.10 % | 7 |
| La Jolla Pharmaceutical Co | LJPC | United States | 0.50 | 15 | 5 | 2 | 6 | 3 | 50.00 % | 25.00 % | 3 |
| Lev Pharmaceuticals Inc | LEVP.PK | United States | -0.12 | 10 | 1 | 2 | 3 | 3 | 37.50 % | 37.50 % | 2 |
| Lpath Inc | HQ8.BE | United States | 1.00 | 1 | 0 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Mannkind Corp | MNKD | United States | -0.07 | 66 | 3 | 7 | 12 | 10 | 42.85 % | 35.71 % | 38 |
| Medarex Inc | MEDX | United States | -0.03 | 264 | 27 | 35 | 88 | 87 | 41.90 % | 41.42 % | 54 |
| Medicines Co | MDCO | United States | 0.20 | 203 | 34 | 19 | 84 | 64 | 50.00 % | 38.09 % | 35 |
| Medicure Inc | NGQ.BE | Canada | -0.50 | 22 | 4 | 9 | 6 | 11 | 30.00 % | 55.00 % | 2 |
| Medizone Intl Inc | MZEI.PK | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Memory Pharmaceuticals Corp | MEMY | United States | 0.37 | 11 | 3 | 1 | 3 | 2 | 37.50 % | 25.00 % | 3 |
| Methylgene Inc | MYG.TO | Canada | -2.00 | 1 | 0 | 1 | 0 | 1 | 0.00 % | 100.00 % | 0 |
| Mgi Pharma Inc | MOGN | United States | -1.97 | 241 | 1 | 217 | 1 | 218 | 0.45 % | 99.54 % | 22 |
| Mymetics Corp | MYMX.OB | United States | -0.66 | 3 | 0 | 1 | 0 | 1 | 0.00 % | 33.33 % | 0 |
| Nabi Biopharmaceuticals | NB1.BE | United States | 0.00 | 125 | 14 | 11 | 37 | 40 | 39.78 % | 43.01 % | 32 |
| Neopharm Inc | NEOL | United States | -0.59 | 40 | 1 | 8 | 4 | 19 | 10.81 % | 51.35 % | 3 |
| Neurocrine Biosciences Inc | NBIX | United States | -0.07 | 152 | 19 | 17 | 44 | 54 | 38.93 % | 47.78 % | 39 |
| Neurogen Corp | NRGN | United States | -0.20 | 80 | 6 | 11 | 20 | 29 | 29.85 % | 43.28 % | 13 |
| Newron Pharmaceuticals Spa | NP5.BE | Italy | -2.00 | 2 | 0 | 1 | 0 | 1 | 0.00 % | 100.00 % | 1 |
| Nitromed Inc | NTMD | United States | -0.12 | 11 | 1 | 0 | 1 | 3 | 12.50 % | 37.50 % | 3 |
| Northwest Biotherapeutics ... | NBYA.BE | United States | -2.00 | 1 | 0 | 1 | 0 | 1 | 0.00 % | 100.00 % | 0 |
| Nurx Pharmaceuticals Inc | NURX.PK | United States | -2.00 | 1 | 0 | 1 | 0 | 1 | 0.00 % | 100.00 % | 0 |
| Nuvelo Inc | NUVO | United States | -0.21 | 63 | 6 | 12 | 19 | 25 | 33.33 % | 43.85 % | 6 |
| Oncolytics Biotech Inc | ONCY | Canada | -0.35 | 22 | 3 | 6 | 6 | 10 | 30.00 % | 50.00 % | 2 |
| Onyx Pharmaceuticals Inc | ONXX | United States | -0.30 | 347 | 34 | 79 | 103 | 138 | 39.46 % | 52.87 % | 86 |
| Osiris Therapeutics Inc | OSIR | United States | 0.27 | 74 | 8 | 6 | 29 | 16 | 52.72 % | 29.09 % | 19 |
| Pharmacopeia Inc | PCOP | United States | -0.27 | 57 | 7 | 12 | 15 | 25 | 27.77 % | 46.29 % | 3 |
| Pharmacyclics Inc | PCYC | United States | -0.54 | 42 | 1 | 9 | 8 | 20 | 21.62 % | 54.05 % | 5 |
| Pharmaxis Ltd | PXSL | Australia | -0.80 | 8 | 0 | 2 | 0 | 2 | 0.00 % | 40.00 % | 3 |
| Point Therapeutics Inc | PJU.BE | United States | -2.00 | 9 | 0 | 8 | 0 | 8 | 0.00 % | 100.00 % | 1 |
| Progenics Pharmaceuticals ... | PGNX | United States | -0.20 | 204 | 26 | 48 | 69 | 81 | 41.56 % | 48.79 % | 38 |
| Protalex Inc | P4K.BE | United States | 0.50 | 2 | 0 | 0 | 1 | 0 | 50.00 % | 0.00 % | 0 |
| Qlt Inc | QLTI | Canada | 0.00 | 83 | 13 | 11 | 28 | 30 | 36.84 % | 39.47 % | 7 |
| Questcor Pharmaceuticals Inc | QSC | United States | 0.54 | 59 | 19 | 7 | 32 | 14 | 58.18 % | 25.45 % | 4 |
| Renovis Inc | RNVS | United States | -0.30 | 56 | 3 | 9 | 11 | 20 | 22.44 % | 40.81 % | 7 |
| Sciclone Pharmaceuticals Inc | SCLN | United States | 0.14 | 38 | 2 | 3 | 13 | 7 | 37.14 % | 20.00 % | 3 |
| Sirtex Medical Limited | SXMDF.PK | Australia | | | | | | | % | % | 1 |
| Spectrum Pharmaceuticals Inc | SPPI | United States | -0.33 | 57 | 4 | 14 | 18 | 26 | 33.33 % | 48.14 % | 3 |
| Stina Resources Ltd | STNUF | Canada | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Sunesis Pharmaceuticals Inc | SNSS | United States | 1.00 | 5 | 1 | 0 | 1 | 0 | 50.00 % | 0.00 % | 3 |
| Symbollon Pharmaceuticals ... | SYMBA.PK | United States | 2.00 | 1 | 1 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Synvista Therapeutics Inc | AWXA.BE | United States | 0.25 | 13 | 2 | 0 | 3 | 2 | 25.00 % | 16.66 % | 1 |
| Tapestry Pharmaceuticals Inc | TPPH | United States | -0.72 | 18 | 0 | 6 | 3 | 10 | 16.66 % | 55.55 % | 0 |
| Theragenics Corp | TGX | United States | -0.09 | 101 | 12 | 12 | 29 | 37 | 34.11 % | 43.52 % | 16 |
| Therapeutics Bangladesh Ltd | TBL.DSE | Bangladesh | 2.00 | 1 | 1 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Theratech Inc | TQ8.BE | United States | 1.33 | 8 | 3 | 0 | 5 | 0 | 83.33 % | 0.00 % | 2 |
| Theravance Inc | THRX | United States | -0.02 | 177 | 17 | 31 | 65 | 55 | 47.10 % | 39.85 % | 39 |
| Threshold Pharmaceuticals ... | THLD | United States | -0.17 | 25 | 3 | 3 | 6 | 10 | 26.08 % | 43.47 % | 2 |
| Titan Pharmaceuticals Inc | TTP | United States | -0.08 | 49 | 5 | 8 | 14 | 15 | 31.11 % | 33.33 % | 4 |
| Tong Ren Tang Technologie ... | TGRNF.PK | China | -2.00 | 1 | 0 | 1 | 0 | 1 | 0.00 % | 100.00 % | 0 |
| Transition Therapeutics Inc | TTHI | Canada | 0.13 | 35 | 3 | 3 | 11 | 7 | 37.93 % | 24.13 % | 6 |
| Trimeris Inc | TRMS | United States | 0.02 | 79 | 9 | 8 | 26 | 25 | 38.23 % | 36.76 % | 11 |
| Trubion Pharmaceuticals Inc | TRBN | United States | 0.30 | 52 | 7 | 3 | 18 | 11 | 50.00 % | 30.55 % | 16 |
| United Therapeutics Corp | UTHR | United States | 0.18 | 424 | 67 | 45 | 162 | 124 | 50.15 % | 38.39 % | 101 |
| Vanda Pharmaceuticals Inc | VNDA | United States | -0.03 | 120 | 15 | 18 | 43 | 43 | 45.74 % | 45.74 % | 26 |
| Via Pharmaceuticals Inc | VIAP | United States | 0.05 | 17 | 2 | 1 | 4 | 4 | 23.52 % | 23.52 % | 0 |
| Vion Pharmaceuticals Inc | VION | United States | -1.75 | 45 | 1 | 36 | 2 | 39 | 4.87 % | 95.12 % | 4 |
| Vivus Inc | VVUS | United States | 0.22 | 149 | 22 | 10 | 60 | 45 | 50.84 % | 38.13 % | 31 |
| Vodone Ltd | VODOF.PK | Bermuda | 0.00 | 2 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 1 |
| Warner Chilcott Limited | WCRX | Bermuda | 0.13 | 145 | 17 | 16 | 64 | 49 | 52.03 % | 39.83 % | 22 |
| Ym Biosciences Inc | YMI | Canada | -0.17 | 30 | 4 | 5 | 8 | 12 | 27.58 % | 41.37 % | 1 |